Frontier IP hails the progress of portfolio company The Vaccines Group
Frontier said the headway made by TVG during the past year is likely to result in a "material valuation uplift” of its stake in the business
Company
Frontier IP Group PLC
LON:FIPP
Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs. The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.
362 stories · page 8 of 19
Frontier IP says gum disease project receives proof-of-concept grant
Built around the work of Cambridge researcher Dr Ioanna Mela, the investigation will attempt to identify at least one DNA nanostructure to take forward into commercial development
Hardware & electrical equipment
Frontier IP Group says Elute Intelligence launches Patent Reader product to user group
The group includes users from multinationals, high-tech SMEs and professional IP services providers whose feedback will be used to refine the functionality of the product
Frontier IP Group says portfolio company Exscientia has raised $60mln through a Series C financing round
The new capital will be used to expand Exscientia's existing portfolio and pipeline and to accelerate international expansion, including in the USA
Archive
Small Cap Wrap - Frontier IP Group; Anglo African Oil & Gas; ReNeuron: C4X Discovery
Banquet Buffet Frontier IP Group 69.5p £35.22m (AIM:FIPP) The Specialist in commercialising intellectual property, notes that portfolio company Exscientia, a world leader in AI-driven drug discovery, has entered into a collaboration with US
Frontier IP portfolio firm Exscientia enters drug discovery collaboration with SRI International
The agreement will see Escientia and SRI implement a new approach to drug discovery using automated synthetic-chemistry and AI
Frontier IP says portfolio firm Molendotech raises funds to accelerate development of bacteria tests
The group said Molendotech’s testing technology has attracted “strong interest internationally” from potential customers concerned about secondary infections during the coronavirus pandemic
Archive
Small Cap Wrap - Frontier IP; Ariana Resources and more...
Ariana Resources 3.45p £36.56m (AIM:AAU) Preliminary production results for the quarter ended 31 March 2020 for the Kiziltepe Mine (50%). · Gold production for the quarter was 5,129 ounces (Q4 2019: 7,318 ounces#), exceeding average annuali
Frontier IP higher as Pulsiv Solar awarded Japanese patent
The patents cover Pulsiv’s power conversion and solar microinverter technologies and are the 13th awarded globally
Frontier IP’s Alusid launches luxury furniture brand
The Block brand, which has been launched by Alusid in collaboration with design consultancy Collective HQ, will initially make small-to-medium-sized occasional tables
Frontier IP notes portfolio company Exscientia to progress compounds that could rapidly become viable drugs for treating coronavirus
The move is a joint initiative with Diamond Light Source and Calibr, a division of Scripps Research (USA)
Frontier IP’s Elute Intelligence launches online coronavirus document reader
Elute's advanced software tools will allow researchers to search for articles mentioning terms related to the outbreak
Hardware & electrical equipment
Frontier IP expands portfolio with software firm AquaInSilico
The new company is developing tools and algorithms to diagnose problems with wastewater treatment systems before they can be detected by humans
Frontier IP companies tackling coronavirus on numerous fronts
At end 2019, the net asset value of the portfolio was 46.6p, up from 41.4p in June, while cash balances stood at £4mln
Hardware & electrical equipment
Frontier IP partners with University of Lisbon for tech transfer competition
The ScienceIN2Business competition invites academics to put forward projects with commercial potential, five of which are then chosen to be taken further
Hardware & electrical equipment
Coronavirus vaccine news "false dawn" for markets, analyst says
The first human trials have started in the US while Russia and China are ramping up developments too
Frontier IP investee company making significant progress; has started work on vaccine to prevent animal to human spread of coronavirus
Frontier chief executive Neil Crabb lauded the progress made by The Vaccines Group
Hardware & electrical equipment
Frontier IP’s Cambridge Raman Imaging Limited secures €140,000 grant to accelerate development of scanning microscope
CRIL is developing a microscope which uses graphene to modulate ultra-short pulses of light to diagnose and track cancer tumours
Hardware & electrical equipment
Frontier IP ups stake in AI logistics firm Celerum
Celerum is a spin-out from Robert Gordon University in Aberdeen to commercialise the work of professor John McCall, the head of its computing, science and digital media school
Hardware & electrical equipment
Frontier IP’s Exscientia begins clinical trial for world’s first AI-created drug
The DSP-1181 drug, created as part of a joint development agreement with Japanese firm Sumitomo Dainippon Pharma, is designed to treat OCD